Close Menu

NEW YORK – Predictive Technology Group and Atrin Pharmaceuticals have partnered to develop molecular diagnostics to expedite improved selection of cancer patients who will benefit from treatment with DNA damage and response (DDR) inhibitors.

The partners plan to develop actionable predictive molecular and companion diagnostics and therapeutics for common disorders and related cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.